Wednesday, May 25, 2016

BRIEF-Spero Therapeutics to acquire worldwide rights to Vertex's VXC-486/VXC-100

* Deal to acquire worldwide rights to VXC-486/VXC-100 and a

portfolio of innovative antibacterial compounds

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)